These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3546871)

  • 21. Hyperuricemia in kidney transplant recipients with intact graft function.
    Kim KM; Kim SS; Han DJ; Yang WS; Park JS; Park SK
    Transplant Proc; 2010 Nov; 42(9):3562-7. PubMed ID: 21094816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elderly renal transplant recipients and renal dysfunction: a risk factor for hyperuricemia.
    Einollahi B; Einollahi H; Rostami Z
    Exp Clin Transplant; 2011 Dec; 9(6):376-80. PubMed ID: 22142044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
    Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
    Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Uric Acid and Renal Transplantation Outcomes: At Least 3-Year Post-transplant Retrospective Multivariate Analysis.
    Zhang K; Gao B; Wang Y; Wang G; Wang W; Zhu Y; Yao L; Gu Y; Chen M; Zhou H; Fu Y
    PLoS One; 2015; 10(7):e0133834. PubMed ID: 26208103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
    Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV
    Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urateoxidase in severe hyperuricemia during acute renal failure after heart transplantation.
    Ippoliti G; Negri M; Abelli P; Martinelli L; Minzioni G; Viganò M
    Haematologica; 1990; 75(5):487-8. PubMed ID: 2097272
    [No Abstract]   [Full Text] [Related]  

  • 29. Hyperuricemia and chronic kidney disease: an enigma yet to be solved.
    Dousdampanis P; Trigka K; Musso CG; Fourtounas C
    Ren Fail; 2014 Oct; 36(9):1351-9. PubMed ID: 25112538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of hyperuricemia on renal function in pediatric renal transplant recipients.
    Fidan C; Kantar A; Baskın E; Gülleroğlu K; Akdur A; Moray G; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():247-50. PubMed ID: 25894164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunological studies on renal transplantation. I. Clinical and experimental studies on immunosuppression by combined use of azathioprine and mizoribine].
    Matsuura T; Kunikata S; Kanda H; Iguchi M; Akiyama T; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 1984 Feb; 75(2):255-62. PubMed ID: 6379251
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclosporin induced hyperuricemia and gout.
    Deray G; Assogba U; Le Hoang P; Brillet G; Baumelou B; Ben Hmida M; Jacobs C
    Clin Nephrol; 1990 Mar; 33(3):154. PubMed ID: 2323116
    [No Abstract]   [Full Text] [Related]  

  • 33. Uric acid contributes to glomerular filtration rate deterioration in renal transplantation.
    Kim KM; Kim SS; Yun S; Lee MS; Han DJ; Yang WS; Park JS; Park SK
    Nephron Clin Pract; 2011; 118(2):c136-42. PubMed ID: 21150221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies on hyperuricemia and gout after transplantation].
    Imanishi M; Ikegami M; Ishii T; Nishioka T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1990 Aug; 36(8):893-6. PubMed ID: 2239590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperuricemia in adult renal allograft recipients: prevalence and predictors.
    Malheiro J; Almeida M; Fonseca I; Martins LS; Pedroso S; Dias L; Henriques AC; Cabrita A
    Transplant Proc; 2012 Oct; 44(8):2369-72. PubMed ID: 23026595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mizoribine as an alternative to azathioprine in triple therapy immunosuppressant regimens in cadaveric renal transplantation: two successive studies.
    Lee HA; Slapak M; Raman GV; Mason JC; Digard N; Wise M
    Transplant Proc; 1995 Feb; 27(1):1050-1. PubMed ID: 7878799
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum metabolomics study of the acute graft rejection in human renal transplantation based on liquid chromatography-mass spectrometry.
    Zhao X; Chen J; Ye L; Xu G
    J Proteome Res; 2014 May; 13(5):2659-67. PubMed ID: 24641727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study on sequential colon dialysis, hemodialysis and peritoneal dialysis in patients with hyperuricemia].
    Wang HT; Chen Y; Huang YH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jun; 27(6):492-4. PubMed ID: 17633357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trial of Bredinin in renal transplantation.
    Inou T; Kusaba R; Takahashi I; Sugimoto H; Kuzuhara K; Yamada Y; Yamauchi J; Otsubo O
    Transplant Proc; 1980 Sep; 12(3):526-8. PubMed ID: 7013183
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of mizoribine on canine renal allograft recipients.
    Gregory CR; Gourley IM; Haskins SC; Cain GR; Ishizaki G; Cowgill LD; Willits NH; Patz JD
    Am J Vet Res; 1988 Mar; 49(3):305-11. PubMed ID: 3282456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.